Glenmark Recalls Mometasone Furoate Cream Due to Gritty Texture Complaints
Glenmark Pharmaceuticals is recalling Mometasone Furoate Cream 0.1% because patients reported the product felt gritty. The recall covers 15g and 45g tubes distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible health consequences. The specific complaint of a gritty texture suggests a quality deviation rather than a severe safety hazard like contamination or mislabeling of active ingredients.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is recalling Mometasone Furoate Cream USP, 0.1%, in 15-gram and 45-gram tubes. The recall was initiated after the company received complaints stating that the cream was gritty.
The affected product is a prescription-only topical medication manufactured in India and distributed nationwide within the United States. The recall includes specific lot numbers with expiration dates ranging from July 2019 to August 2020.
Consumers should stop using the affected product and return it to their pharmacy or contact Glenmark Pharmaceuticals for instructions on how to proceed.
The recalled product
- Product
- MOMETASONE FUROATE (MOMETASONE FUROATE)
- Brand
- MOMETASONE FUROATE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Topical Steroid
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- a) 05171238
- 05171248
- 05171249
- Exp. Jul-2019
- 05171582
- 05171612
- Exp. Aug-2019
- 05171674
- 05171675
- 05171682
- Exp. Sep 2019
- 05180065
- 05180066
- Exp. Dec 2019
- 05180264
- 05180265
- 05180275
- 0518276
- Exp. Jan 2020
- 05180411
UPCs (1)
- 0368462192559
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · MOMETASONE FUROATE
- LowMometasone Furoate Topical Solution Recalled Due to Defective Containers
FDA (Drugs) · 2022-07-13
Same manufacturer · Glenmark Pharmaceuticals Inc., USA
See all →- ModerateAzelaic Acid Gel 15% Recalled Over Grainy, Gritty, or Sandy Texture
FDA (Drugs) · 2026-08-05
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24
- ModerateOndansetron tablets recalled because blister packs are not fully sealed
FDA (Drugs) · 2026-01-07
- CriticalFrozen chopped methi recalled after testing positive for Salmonella
FDA (Drugs) · 2025-12-17
- ModerateBisoprolol and hydrochlorothiazide tablets recalled over traces of another drug
FDA (Drugs) · 2025-12-10
Same hazard · quality deviation
See all →- ModerateNarcan Nasal Spray Recalled for Temperature Excursions During Storage
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Meloxicam Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls LYRICA Capsules Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Advair HFA Inhalers Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Oseltamivir Phosphate Oral Suspension Due to Temperature Excursions
FDA (Drugs) · 2021-06-02